Search

Search Constraints

You searched for: Author/Creator Douglas, Jeffrey

Search Results

2. A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α, 24(S)Dihydroxyvitamin D2) in patients with advanced cancer. (December 2015)